<DOC>
	<DOCNO>NCT01144221</DOCNO>
	<brief_summary>This evaluative , monocentric study patient chronic ischemic heart disease leave bundle branch block receive ICD-CRT . It early investigation safety effect single administration bone marrow derive mononuclear cell implantation ICD-CRT device adjunct CRT usual drug treatment .</brief_summary>
	<brief_title>Bone Marrow Derived Mononuclear Cells Ischemic Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>chronic leave ventricular dysfunction ( ejection fraction &lt; 35 % ) chronic ischemic heart disease asynchronic contraction indication biventricular stimulation ( CRT , chronic resynchronization therapy ) , improvement &gt; 15 % LVEF 3 month CRTdevice implantation wall motion dysfunction territory leave bundle branch block Patients individual optimal treatment chronic ischemic heart disease one combination follow drug type : diuretic , ÃŸblockers , ACEinhibitors , AT1 blocker and/or lipid lower agent least 30 day CRT Implantation patient leave ventricular dysfunction due reason ischemic cardiomyopathy , e.g . hypertension , dilatative cardiomyopathy relevant valvular disease ; Aneurysma anterior myocardial wall myocardial wall thickness &lt; 5 mm , overt heart failure , ischemic cardiomyopathy , history stroke and/or transient ischemic attack ( TIA ) , history thromboembolic event ( e.g . phlebothrombosis , pulmonary embolism ) , bleed disorder know disease coagulation system ; extensive deviation baseline laboratory value significant finding physical examination opinion investigator may worsen treatment ; severe systemic disease ( e.g . know suspected anaphylaxia , intolerance Xray contrast agent , premalignant malignant disease ) atrial fibrillation average heart rate &gt; 70 bpm pregnant woman woman childbearing potential negative pregnancy test within 48 hour treatment ; disease condition seriously compromise function body system heart and/or might interfere conduct study interpretation result ; patient chronic acute HIV , HBV , HCVinfection ; improvement 15 % LVEF 3 month CRTdevice implantation patient ICD Implantation secondary prophylactic indication . These patient show history resuscitation , VT syncope . patient currently participate another investigational drug device study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Chronic Ischemic Heart Disease</keyword>
</DOC>